• 2020
  Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S, , A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations., Sci Transl Med 2020 09; 12(559): .
• 2020
  Gámbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, Vanpeene M, Bizard M, Brisebarre A, Barbet M, Derrar F, van der Werf S, Enouf V, Simon-Loriere E, , Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
• 2015
  Souty C, Blanchon T, Bonmarin I, Lévy-Bruhl D, Behillil S, Enouf V, Valette M, Bouscambert M, Turbelin C, Capai L, Roussel V, Hanslik T, Falchi A, Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France, Hum Vaccin Immunother 2015 Jul;11(7):1621-5.
• 2015
  Munoz O, De Nardi M, van der Meulen K, van Reeth K, Koopmans M, Harris K, von Dobschuetz S, Freidl G, Meijer A, Breed AC, Hill A, Kosmider R, Banks J, Stärk KD, Wieland B, Stevens K, van der Werf S, Enouf V, Dauphin G, Dundon W, Cattoli G, Capua I, , Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 May;.
• 2015
  Broberg E, Snacken R, Adlhoch C, Beauté J, Galinska M, Pereyaslov D, Brown C, Penttinen P, , Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype, Euro Surveill. 2015;20(4).
• 2015
  Munoz O, De Nardi M, van der Meulen K, van Reeth K, Koopmans M, Harris K, von Dobschuetz S, Freidl G, Meijer A, Breed A, Hill A, Kosmider R, Banks J, Stärk KD, Wieland B, Stevens K, van der Werf S, Enouf V, Dauphin G, Dundon W, Cattoli G, Capua I, , Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 Jan;.
• 2014
  Freidl GS, Meijer A, de Bruin E, de Nardi M, Munoz O, Capua I, Breed AC, Harris K, Hill A, Kosmider R, Banks J, von Dobschuetz S, Stark K, Wieland B, Stevens K, van der Werf S, Enouf V, van der Meulen K, Van Reeth K, Dauphin G, Koopmans M, , Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1), Euro Surveill. 2014;19(18).
• 2013
  Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis 2014 Jan;14(1):50-56.
• 2013
  Ploin D, Chidiac C, Carrat F, Cohen B, Javouhey E, Mayaud C, Desenclos JC, Lina B, Leport C, , Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort, J. Clin. Virol. 2013 Sep;58(1):114-9.
• 2013
  Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, Campese C, Guéry B, Prouvost H, Lemaire X, Paty MC, Haeghebaert S, Antoine D, Ettahar N, Noel H, Behillil S, Hendricx S, Manuguerra JC, Enouf V, La Ruche G, Semaille C, Coignard B, Lévy-Bruhl D, Weber F, Saura C, Che D, , First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013, Euro Surveill. 2013;18(24).
• 2013
  Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S, , Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission, Lancet 2013 Jun;381(9885):2265-72.
• 2013
  Pozo F, Lina B, Andrade HR, Enouf V, Kossyvakis A, Broberg E, Daniels R, Lackenby A, Meijer A, Community Network of Reference Laboratories for Human Influenza in Europe , Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe, J. Clin. Virol. 2013 May;57(1):5-12.
• 2012
  Heraud JM, Njouom R, Rousset D, Kadjo H, Caro V, Ndiaye MN, Victoir K, Collard JM, Orelle A, Yekwa EL, Ekaza E, Razanajatovo NH, Adamou L, Biscornet L, Enouf V, van der Werf S, Diop OM, Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network, J. Infect. Dis. 2012 Dec;206 Suppl 1:S5-13.
• 2012
  LeGoff J, Rousset D, Abou-Jaoudé G, Scemla A, Ribaud P, Mercier-Delarue S, Caro V, Enouf V, Simon F, Molina JM, van der Werf S, I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y, PLoS ONE 2012;7(8):e37095.
• 2012
  Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B, Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections, Antiviral Res. 2012 Nov;96(2):130-7.
• 2012
  Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC, HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains, Vaccine 2012 Jul;30(35):5262-9.
• 2012
  Bone A, Guthmann JP, Assal A, Rousset D, Degeorges A, Morel P, Valette M, Enouf V, Jacquot E, Pelletier B, Le Strat Y, Pillonel J, Fonteneau L, van der Werf S, Lina B, Tiberghien P, Lévy-Bruhl D, Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France, PLoS ONE 2012;7(3):e33056.
• 2012
  Blanchon T, Mentré F, Charlois-Ou C, Dornic Q, Mosnier A, Bouscambert M, Carrat F, Duval X, Enouf V, Leport C, , Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter, Clin. Microbiol. Infect. 2013 Feb;19(2):196-203.
• 2011
  Lina B, Bouscambert M, Enouf V, Rousset D, Valette M, van der Werf S, S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses, Euro Surveill. 2011;16(50):20039.
• 2011
  Pelletier I, Rousset D, Enouf V, , Colbere-Garapin F, van der Werf S, Naffakh N, Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France, Euro Surveill. 2011 Oct;16(43).
• 2011
  Amato-Gauci A, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, Penttinen P, Nicoll A, , Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe, Euro Surveill. 2011;16(26).
• 2011
  Rosenkrands I, Vingsbo-Lundberg C, Bundgaard TJ, Lindenstrøm T, Enouf V, van der Werf S, Andersen P, Agger EM, Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes, Vaccine 2011 Aug;29(37):6283-91.
• 2011
  Papillard-Marechal S, Enouf V, Schnuriger A, Vabret A, Macheras E, Rameix-Welti MA, Page B, Freymuth F, van der Werf S, Garbarg-Chenon A, Chevallier B, Gaillard JL, Gault E, Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus, J. Med. Virol. 2011 Apr;83(4):695-701.
• 2011
  Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S, Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution, Antivir. Ther. (Lond.) 2011;16(4):597-603.
• 2010
  Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A, , , Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009, Euro Surveill. 2010 Dec;15(49).
• 2010
  Duval X, van der Werf S, Blanchon T, Mosnier A, Bouscambert-Duchamp M, Tibi A, Enouf V, Charlois-Ou C, Vincent C, Andreoletti L, Tubach F, Lina B, Mentré F, Leport C, , Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial, PLoS Med. 2010;7(11):e1000362.
• 2009
  Buchy P, Fourment M, Mardy S, Sorn S, Holl D, Ly S, Vong S, Enouf V, Peiris JS, van der Werf S, Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007, Emerging Infect. Dis. 2009 Oct;15(10):1641-4.
• 2009
  Charlier C, Enouf V, Lanternier F, Grandadam M, Amazzough K, Blanche S, Lecuit M, Lortholary O, van der Werf S, Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy, Clin. Microbiol. Infect. 2009 Dec;15(12):1189-91.
• 2009
  , Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries, Euro Surveill. 2009 Jun;14(23):19238.
• 2009
  Surcouf C, Fabre M, Enouf V, Cadé S, Soler C, Mac Nab C, Samson T, Foissaud V, [Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?], Pathol. Biol. 2011 Jun;59(3):146-50.
• 2009
  Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M, , Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season, Emerging Infect. Dis. 2009 Apr;15(4):552-60.
• 2009
  Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, Rozenberg F, Caudie C, Annane D, van der Werf S, Lebon P, Raphaël JC, Gaillard JL, Gault E, Guillain-Barré syndrome and influenza virus infection, Clin. Infect. Dis. 2009 Jan;48(1):48-56.
• 2008
  Rameix-Welti MA, Enouf V, Cuvelier F, Jeannin P, van der Werf S, Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir, PLoS Pathog. 2008 Jul;4(7):e1000103.
• 2007
  Maslin J, Bigaillon C, Froussard F, Enouf V, Nicand E, Acute bilateral uveitis associated with an active human herpesvirus-6 infection, J. Infect. 2007 Apr;54(4):e237-40.
• 2006
  Caron M, Enouf V, Than SC, Dellamonica L, Buisson Y, Nicand E, Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia, J. Clin. Microbiol. 2006 Sep;44(9):3440-2.
• 2006
  Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, Nicand E, Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens, J. Med. Virol. 2006 Aug;78(8):1076-82.
• 2005
  Nicand E, Armstrong GL, Enouf V, Guthmann JP, Guerin JP, Caron M, Nizou JY, Andraghetti R, Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad, J. Med. Virol. 2005 Dec;77(4):519-21.
• 2004
  Grandadam M, Tebbal S, Caron M, Siriwardana M, Larouze B, Koeck JL, Buisson Y, Enouf V, Nicand E, Evidence for hepatitis E virus quasispecies, J. Gen. Virol. 2004 Nov;85(Pt 11):3189-94.
• 2003
  Enouf V, Chwetzoff S, Trugnan G, Cohen J, Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1, J. Virol. 2003 Jun;77(12):7041-7.
• 2002
  Sapin C, Colard O, Delmas O, Tessier C, Breton M, Enouf V, Chwetzoff S, Ouanich J, Cohen J, Wolf C, Trugnan G, Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells, J. Virol. 2002 May;76(9):4591-602.
• 2001
  Enouf V, Langella P, Commissaire J, Cohen J, Corthier G, Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol. 2001 Apr;67(4):1423-8.